Animalcare Group PLC
LSE:ANCR

Watchlist Manager
Animalcare Group PLC Logo
Animalcare Group PLC
LSE:ANCR
Watchlist
Price: 240 GBX 1.27% Market Closed
Market Cap: 165.6m GBX
Have any thoughts about
Animalcare Group PLC?
Write Note

Animalcare Group PLC
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Animalcare Group PLC
Gross Profit Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Animalcare Group PLC
LSE:ANCR
Gross Profit
ÂŁ43.1m
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
20%
GlaxoSmithKline PLC
LSE:GSK
Gross Profit
ÂŁ22.9B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
3%
AstraZeneca PLC
LSE:AZN
Gross Profit
$40.4B
CAGR 3-Years
22%
CAGR 5-Years
17%
CAGR 10-Years
7%
Verona Pharma PLC
NASDAQ:VRNA
Gross Profit
$5.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Gross Profit
$1.4B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
5%
Dechra Pharmaceuticals PLC
LSE:DPH
Gross Profit
ÂŁ429.6m
CAGR 3-Years
14%
CAGR 5-Years
14%
CAGR 10-Years
16%
No Stocks Found

Animalcare Group PLC
Glance View

Market Cap
165.6m GBX
Industry
Pharmaceuticals

Animalcare Group Plc engages in the development, sale, and supply of generic veterinary medicines and animal identification products. The company is headquartered in Ripon, North Yorkshire. The company went IPO on 2008-01-15. The firm is focused on developing and commercializing prescription and over-the-counter pharmaceutical products. The firm operates in three categories within the veterinary market, which includes Companion Animals, Equine and Production Animals. The company manages international supply chain, including specialist veterinary wholesalers and distributors. The firm develops, supplies and markets products and services to the veterinary profession. The company focuses on therapeutic areas, which includes pain management, dermatology and anti-infectives. The Company’s product pipeline is Daxocox, which is a differentiated COX-2 inhibitor for the treatment of chronic pain in dogs.

ANCR Intrinsic Value
337.91 GBX
Undervaluation 29%
Intrinsic Value
Price

See Also

What is Animalcare Group PLC's Gross Profit?
Gross Profit
43.1m GBP

Based on the financial report for Jun 30, 2024, Animalcare Group PLC's Gross Profit amounts to 43.1m GBP.

What is Animalcare Group PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
20%

Over the last year, the Gross Profit growth was 11%. The average annual Gross Profit growth rates for Animalcare Group PLC have been 3% over the past three years , 3% over the past five years , and 20% over the past ten years .

Back to Top